Global healthcare stocks have not been this cheap in decades and fund inflows into the sector are picking up, yet the shares ...

Abbott Laboratories (NYSE:ABT) is one of the stocks that Jim Cramer shed light on. Commenting on the company’s recent ...

Alberto Conca, CIO at Swiss wealth manager LFG+ZEST, has been adding exposure to pharma, biotech and medtech in recent weeks, ...

Every investor in Abbott Laboratories (NYSE:ABT) should be aware of the most powerful shareholder groups. And the group that holds the biggest piece of the pie are institutions with 80% ownership. In ...

Consumers remain cautious about potential price hikes, but their biggest concerns about tariff-induced inflation have ...

US Dollar Canadian Dollar, Nasdaq 100, S&P 500, Goldman Sachs Group Inc. Read 's Market Analysis on Investing.com CA.

We recently published Jim Cramer Discusses These 10 Stocks & AI-Led Disinflation. Abbott Laboratories (NYSE:ABT) is one of ...

Healthcare is currently the market’s most oversold sector, which could catch inflows from a risk-off rotation. UNH, ISRG, and ABT are presently the most oversold and provide an interesting opportunity ...

Q2 2025 Earnings Call Transcript July 17, 2025 Abbott Laboratories reports earnings inline with expectations. Reported EPS is ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Abbott Laboratories (NYSE:ABT) has long held a strong position in the heavily regulated healthcare industry. Over the years, ...

According to Benzinga Pro, Abbott Laboratories's peer group average for short interest as a percentage of float is 4.29%, which means the company has less short interest than most of its peers. Did ...